OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease
Yajie Chen, Yang Wang, Ziqiang Cui, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 15
Yajie Chen, Yang Wang, Ziqiang Cui, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 15
Showing 15 citing articles:
Environment, Endocrine Disruptors, and Fatty Liver Disease Associated with Metabolic Dysfunction (MASLD)
Antonella Mosca, Melania Manco, Maria Rita Braghini, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 71-71
Open Access | Times Cited: 11
Antonella Mosca, Melania Manco, Maria Rita Braghini, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 71-71
Open Access | Times Cited: 11
Plastic compounds and liver diseases: Whether bisphenol A is the only culprit
Sonal Sangwan, Rajasri Bhattacharyya, Dibyajyoti Banerjee
Liver International (2024) Vol. 44, Iss. 5, pp. 1093-1105
Closed Access | Times Cited: 8
Sonal Sangwan, Rajasri Bhattacharyya, Dibyajyoti Banerjee
Liver International (2024) Vol. 44, Iss. 5, pp. 1093-1105
Closed Access | Times Cited: 8
Lupeol improves bile acid metabolism and metabolic dysfunction-associated steatotic liver disease in mice via FXR signaling pathway and gut-liver axis
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
Dongmei Qin, P Pan, Bo Lyu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116942-116942
Open Access | Times Cited: 5
Impact of Endocrine Disruptors on Key Events of Hepatic Steatosis in HepG2 Cells
M Grosso, Eliška Řehůřková, Ishita Virmani, et al.
Food and Chemical Toxicology (2025), pp. 115241-115241
Closed Access
M Grosso, Eliška Řehůřková, Ishita Virmani, et al.
Food and Chemical Toxicology (2025), pp. 115241-115241
Closed Access
Age-Dependent Effects of Butyl Benzyl Phthalate Exposure on Lipid Metabolism and Hepatic Fibrosis in Mice
Min-Seo Park, Seonhwa Hwang, Hong‐Yo Kang, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 126-126
Open Access
Min-Seo Park, Seonhwa Hwang, Hong‐Yo Kang, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 126-126
Open Access
The hepatocellular model of fatty liver disease: from current imaging diagnostics to innovative proteomics technologies
Renee Hernandez, Natasha S. Garcia-Rodriguez, Marco A. Arriaga, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Renee Hernandez, Natasha S. Garcia-Rodriguez, Marco A. Arriaga, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
The association between endocrine disrupting chemicals and nonalcoholic fatty liver disease: A systematic review and meta-analysis
Kai Pan, Jie Xu, Yuzhu Xu, et al.
Pharmacological Research (2024) Vol. 205, pp. 107251-107251
Open Access | Times Cited: 3
Kai Pan, Jie Xu, Yuzhu Xu, et al.
Pharmacological Research (2024) Vol. 205, pp. 107251-107251
Open Access | Times Cited: 3
Associations of exposure to bisphenol-A or parabens with markers of liver injury/function among US adults in NHANES 2011–2016
Rongkun Luo, Mingcong Chen, Shuai Hao, et al.
Journal of Exposure Science & Environmental Epidemiology (2024)
Closed Access | Times Cited: 3
Rongkun Luo, Mingcong Chen, Shuai Hao, et al.
Journal of Exposure Science & Environmental Epidemiology (2024)
Closed Access | Times Cited: 3
Metabolic disrupting chemicals in the intestine: the need for biologically relevant models
Chedi Erradhouani, Sylvie Bortoli, Sélim Aït‐Aïssa, et al.
FEBS Open Bio (2024) Vol. 14, Iss. 9, pp. 1397-1419
Open Access | Times Cited: 3
Chedi Erradhouani, Sylvie Bortoli, Sélim Aït‐Aïssa, et al.
FEBS Open Bio (2024) Vol. 14, Iss. 9, pp. 1397-1419
Open Access | Times Cited: 3
Advancing Endocrine Disruptors via In Vitro Evaluation: Recognizing the Significance of the Organization for Economic Co-Operation and Development and United States Environmental Protection Agency Guidelines, Embracing New Assessment Methods, and the Urgent Need for a Comprehensive Battery of Tests
Sophie Fouyet, Marie-Caroline Ferger, P. Leproux, et al.
Toxics (2024) Vol. 12, Iss. 3, pp. 183-183
Open Access | Times Cited: 2
Sophie Fouyet, Marie-Caroline Ferger, P. Leproux, et al.
Toxics (2024) Vol. 12, Iss. 3, pp. 183-183
Open Access | Times Cited: 2
Synthetic phenolic compounds perturb lipid metabolism and induce obesogenic effects
Hui-Nan Liu, Zhendong Sun, Qian Liu, et al.
Chinese Journal of Chromatography (2024) Vol. 42, Iss. 2, pp. 131-141
Open Access | Times Cited: 1
Hui-Nan Liu, Zhendong Sun, Qian Liu, et al.
Chinese Journal of Chromatography (2024) Vol. 42, Iss. 2, pp. 131-141
Open Access | Times Cited: 1
Investigation of Environmental Factors as a Key Progression in the Treatment of Fatty Liver Disease: A Study Protocol
Nisha D Barole, Vijendra Kirnake
Cureus (2024)
Open Access
Nisha D Barole, Vijendra Kirnake
Cureus (2024)
Open Access
Persistent effects of di-n-butyl phthalate on liver transcriptome: impaired energy and lipid metabolic pathways
Eleftheria Theodoropoulou, Paula Pierozan, Francesco Marabita, et al.
Chemosphere (2024), pp. 143605-143605
Open Access
Eleftheria Theodoropoulou, Paula Pierozan, Francesco Marabita, et al.
Chemosphere (2024), pp. 143605-143605
Open Access
Polychlorinated Biphenyls and Semen Quality in Healthy Young Men Living in a Contaminated Area
Francesco Donato, Matteo Rota, Elisabetta Ceretti, et al.
Toxics (2023) Vol. 12, Iss. 1, pp. 6-6
Open Access | Times Cited: 1
Francesco Donato, Matteo Rota, Elisabetta Ceretti, et al.
Toxics (2023) Vol. 12, Iss. 1, pp. 6-6
Open Access | Times Cited: 1
Thoughts on Non-Alcoholic Fatty Liver Disease and Chronic Disease.
Joseph E. Pizzorno, Lara Pizzorno
PubMed (2023) Vol. 22, Iss. 2, pp. 6-9
Closed Access
Joseph E. Pizzorno, Lara Pizzorno
PubMed (2023) Vol. 22, Iss. 2, pp. 6-9
Closed Access
